 |
|
|
| |
Direct Acting Antiviral HCV Therapy is Safe and Effective in Patients with
Decompensated Cirrhosis: Real World Experience from the HCV-TARGET Cohort
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Authors: Verna EC, Morelli G, Terrault N, Lok AS, Lim J, Di
Bisceglie AM, Zeuzem S, Landis C, Lutchman G, Hassan M,
Manns M, Vainorius M, Akushevich L, Nelson D, Fried M,
Reddy KR for the HCV-TARGET Study Group
|
| |
|
|
|
|
|
